87 related articles for article (PubMed ID: 31880080)
21. Carbon dots-embedded epitope imprinted polymer for targeted fluorescence imaging of cervical cancer via recognition of epidermal growth factor receptor.
Zhang Y; Li S; Ma XT; He XW; Li WY; Zhang YK
Mikrochim Acta; 2020 Mar; 187(4):228. PubMed ID: 32170469
[TBL] [Abstract][Full Text] [Related]
22. Insights into Interactions between Interleukin-6 and Dendritic Polyglycerols.
Sanader Maršić Ž; Maysinger D; Bonačić-Kouteckỳ V
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670858
[TBL] [Abstract][Full Text] [Related]
23. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
[TBL] [Abstract][Full Text] [Related]
24.
Pyo A; Yun M; Kim HS; Kim TY; Lee JJ; Kim JY; Lee S; Kwon SY; Bom HS; Kim HS; Kim DY; Min JJ
J Nucl Med; 2018 Feb; 59(2):340-346. PubMed ID: 28916621
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20.
Krasniqi A; Bialkowska M; Xavier C; Van der Jeught K; Muyldermans S; Devoogdt N; D'Huyvetter M
N Biotechnol; 2018 Oct; 45():69-79. PubMed ID: 29574274
[TBL] [Abstract][Full Text] [Related]
26. PET imaging of EGFR expression using an
Cheng S; Jacobson O; Zhu G; Chen Z; Liang SH; Tian R; Yang Z; Niu G; Zhu X; Chen X
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):948-956. PubMed ID: 30069577
[TBL] [Abstract][Full Text] [Related]
27. Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.
Goux M; Becker G; Gorré H; Dammicco S; Desselle A; Egrise D; Leroi N; Lallemand F; Bahri MA; Doumont G; Plenevaux A; Cinier M; Luxen A
Bioconjug Chem; 2017 Sep; 28(9):2361-2371. PubMed ID: 28825794
[TBL] [Abstract][Full Text] [Related]
28. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.
Massa S; Xavier C; De Vos J; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Bioconjug Chem; 2014 May; 25(5):979-88. PubMed ID: 24815083
[TBL] [Abstract][Full Text] [Related]
29. Endocytosis and lysosomal targeting of epidermal growth factor receptors are mediated by distinct sequences independent of the tyrosine kinase domain.
Opresko LK; Chang CP; Will BH; Burke PM; Gill GN; Wiley HS
J Biol Chem; 1995 Mar; 270(9):4325-33. PubMed ID: 7876194
[TBL] [Abstract][Full Text] [Related]
30. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
[TBL] [Abstract][Full Text] [Related]
31. Peptide ligand-mediated endocytosis of nanoparticles to cancer cells: Cell receptor-binding- versus cell membrane-penetrating peptides.
Jo E; Heo JS; Lim JY; Lee BR; Yoon CJ; Kim J; Lee J
Biotechnol Bioeng; 2018 Jun; 115(6):1437-1449. PubMed ID: 29460954
[TBL] [Abstract][Full Text] [Related]
32. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
33. Protein Aggregation Nucleated by Functionalized Dendritic Polyglycerols.
Bernhard SP; Fricke MS; Haag R; Cloninger MJ
Polym Chem; 2020 Jun; 11(23):3849-3862. PubMed ID: 35222696
[TBL] [Abstract][Full Text] [Related]
34. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
35. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
36. Be Active or Not: the Relative Contribution of Active and Passive Tumor Targeting of Nanomaterials.
Li R; Zheng K; Yuan C; Chen Z; Huang M
Nanotheranostics; 2017; 1(4):346-357. PubMed ID: 29071198
[TBL] [Abstract][Full Text] [Related]
37. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
38. Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[
Zhou Z; McDougald D; Devoogdt N; Zalutsky MR; Vaidyanathan G
Mol Pharm; 2019 Jan; 16(1):214-226. PubMed ID: 30427188
[TBL] [Abstract][Full Text] [Related]
39. Detecting and Quantifying Biomolecular Interactions of a Dendritic Polyglycerol Sulfate Nanoparticle Using Fluorescence Lifetime Measurements.
Boreham A; Pikkemaat J; Volz P; Brodwolf R; Kuehne C; Licha K; Haag R; Dernedde J; Alexiev U
Molecules; 2015 Dec; 21(1):E22. PubMed ID: 26712722
[TBL] [Abstract][Full Text] [Related]
40. Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation.
Zhou Z; Chitneni SK; Devoogdt N; Zalutsky MR; Vaidyanathan G
Bioorg Med Chem; 2018 May; 26(8):1939-1949. PubMed ID: 29534937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]